Zhejiang Cheng Yi Pharmaceutical Co.,Ltd.

Since its establishment in 1966, the company has actively relied on the advantages of Dongtou as a demonstration zone for marine economic development, vigorously developed marine biomedicine, and developed a workshop-style military family small pharmaceutical company into the first listed pharmaceutical company in Wenzhou and the first listed marine biomedical company in Zhejiang Province. Currently, more than 70 kinds of pharmaceuticals and health foods can be produced. During the “14th Five-Year Plan” period, the focus will be on planning the “two strong and one big” projects for Asia's largest annual output of 2,000 tons of ammonia raw materials and 1,000 tons of super fish oil, accelerate the transformation and upgrading from “generic drugs” to “innovative drugs”, and work hard to become a “leading enterprise” and “leading enterprise” of marine biomedicine in Zhejiang Province. The company focuses on medical and health products, and is a national high-tech enterprise specializing in R&D, production and sales of formulations and APIs. The company's main products include glucosamine hydrochloride raw materials and preparations, Tianmarin APIs, ribavirin preparations and APIs, azathioprine APIs, etc. Corporate honors: National High-tech Enterprise; Provincial Enterprise Research Institute; Zhejiang Enterprise Technology Center; Wenzhou “Academician Expert Workstation”; Wenzhou Medical University Pharmaceutical School New Drug Research Institute; High Quality Development Demonstration Enterprise; Wenzhou Zhongcai Aicai Advanced Unit, etc.